2 April 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce it has entered into a Distribution Agreement with Australian-owned medical distribution company Regional Health Care Group Pty Ltd (RGCH), based in Sydney.
Under the agreement, RHCG will be the exclusive distributor of Imricor’s consumable products in Australia and New Zealand, and a non-exclusive distributor of Imricor’s capital equipment. Importantly, RGCH will also help facilitate the necessary regulatory approvals and support of Imricor’s products in Australia and New Zealand. First approvals are expected by year-end 2021.
Regional Health Care Group (RHCG) is an Australian-owned medical distribution company with over 40 years of experience in the Australian medical industry as a provider of medical consumables, contrast media and capital equipment.
The agreement with RHGC enables MRI manufacturers such as Philips to continue providing Imricor’s capital equipment as part of an overall iCMR lab package.
Imricor’s Chair and CEO, Steve Wedan, said: “We are thrilled to join forces with Regional Healthcare Group to bring Imricor’s products and MRI-guided ablations to Australia and New Zealand. This is an important part of our geographical expansion plans, and we can’t think of a better partner to work with. Together, we look forward to helping improve the care of Australians and New Zealanders struggling with cardiac arrhythmias.”
RHCG General Manager Stephen Doorey added “We are extremely excited to partner with Imricor, their innovative and exciting new solution for Cardiac Ablations is a great addition to our business. RHCG has unrivaled experience in supplying and servicing medical equipment and consumables to the Radiology and Cardiology sector across Australia and New Zealand with over 1,200 devices installed.”